The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing in Elderly Women With Recurrent UTI

PHASE4CompletedINTERVENTIONAL
Enrollment

289

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Recurrent Urinary Tract Infection
Interventions
DRUG

Methenamine Hippurate 1000 MG

Methenamine and placebo is taken 1 tablet morning and evening for 180 days

Trial Locations (4)

3584CX,

Universitair Medisch Centrum Utrecht, Utrecht

NO 0317

University of Oslo, Oslo

90-153

Medical University of Lodz,, Lodz

SE-503 38

Research and Development Primary Health Care, Region Västra Götaland,, Borås

All Listed Sponsors
collaborator

Amsterdam UMC, location VUmc

OTHER

collaborator

UMC Utrecht

OTHER

collaborator

Göteborg University

OTHER

collaborator

Medical University of Lodz

OTHER

lead

University of Oslo

OTHER

NCT04077580 - The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing in Elderly Women With Recurrent UTI | Biotech Hunter | Biotech Hunter